Pat Whitworth ex-Chairman of the American Society of Breast Surgeons and Committee member of TME presents Digistain as a “game changer with its highly disruptive technology” with its ability to streamline throughout in evaluating patient risk for hormone-positive breast cancer.
Digistain Launches First International Lab in South Africa
In our ongoing effort to bring accessible cancer diagnostics to the regions that need them most, we are proud to announce the official launch of
